Vitalhub Corp. (TSE:VHI – Get Free Report) has been assigned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is C$14.86.
VHI has been the topic of several research analyst reports. Scotiabank upped their target price on Vitalhub from C$14.00 to C$14.50 and gave the company an “outperform” rating in a research report on Friday, June 20th. Raymond James Financial upped their target price on Vitalhub from C$14.50 to C$15.00 and gave the company an “outperform” rating in a research report on Tuesday, August 12th. Royal Bank Of Canada set a C$15.00 price target on Vitalhub and gave the stock a “moderate buy” rating in a report on Thursday, September 18th. National Bankshares set a C$16.00 price target on Vitalhub and gave the stock an “outperform” rating in a report on Thursday, August 21st. Finally, Stifel Nicolaus set a C$15.00 price target on Vitalhub and gave the stock a “buy” rating in a report on Wednesday.
Get Our Latest Report on Vitalhub
Insider Activity at Vitalhub
Vitalhub Price Performance
Shares of Vitalhub stock opened at C$10.24 on Monday. Vitalhub has a one year low of C$8.50 and a one year high of C$14.64. The stock’s 50-day moving average is C$11.76 and its 200 day moving average is C$11.34. The firm has a market cap of C$643.38 million, a price-to-earnings ratio of 128.00, a PEG ratio of 1.18 and a beta of 0.62.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Dividend Capture Strategy: What You Need to Know
- This AI Chip Giant Could Be the Market’s Next Big Winner
- How is Compound Interest Calculated?
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Why is the Ex-Dividend Date Significant to Investors?
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.